-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sabestomig in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sabestomig in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sabestomig in Crohn's Disease (Regional Enteritis) Drug Details: Sabestomig (AZD-7789)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Sabestomig in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sabestomig in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sabestomig in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sabestomig in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sabestomig in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sabestomig in Gastric Cancer Drug Details: Sabestomig (AZD-7789) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sabestomig in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sabestomig in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sabestomig in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Thematic Analysis
Global M&A Deals in 2023 – Top Themes by Sector – Thematic Intelligence
If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&As). This report analyzes the disruptive themes that have driven M&A activity in 2023 across all sectors including automotive, basic material, business and consumer services, consumer, energy, financial, healthcare, industrials, real estate, technology, media & telecoms, transportation, infrastructure, and logistics.
-
Company Insights
Restaurant Brands International Inc. – Company Overview and Analysis, 2023 Update
Restaurant Brands International Inc. Overview Restaurant Brand International Inc. (RBI) is a quick-service restaurant (QSR) operator that owns and franchises brands such as Burger King, Tim Hortons, Popeyes, and Firehouse Subs. Headquartered in Toronto, Canada, the company has operations in more than 100 countries across the globe. The "Restaurant Brands International Inc. - Company Overview and Analysis, 2023 Update" report is based on market analysis and brand diversification by industry and geography. The report will help in understanding the challenges...
-
Product Insights
Quarterly Chutneys & Relishes pricing trends in Canada
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Chutneys & Relishes pricing trends in Canada" serves as a crucial resource for...
-
Product Insights
Quarterly Sugar Confectionery pricing trends in Canada
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Sugar Confectionery pricing trends in Canada" serves as a crucial resource for analyzing...
-
Product Insights
Net Present Value Model: Feiba
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Feiba Drug Details Anti-Inhibitor Coagulant Complex...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Sym-023
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Sym-023 Drug Details Sym-023 is under development for the treatment of advanced/ unresectable or...